Search Results - "Lopes, Nilcéia"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Compliance with treatment: related-issues and insights for pharmacist intervention by Silva, Nilcéia Lopes da, Ribeiro, Eliane, Navarro, João Luis, Zanini, Antonio Carlos

    “…Low patient compliance with pharmacotherapy remains one of the greatest challenges for success of treatments, especially in chronic diseases, since it can…”
    Get full text
    Journal Article
  2. 2

    Metabolic Syndrome Patient Compliance with Drug Treatment by Lopes, Nilcéia, Zanini, Antonio Carlos, Casella-Filho, Antonio, Chagas, Antonio Carlos Palandri

    Published in Clinics (São Paulo, Brazil) (01-10-2008)
    “…1) To evaluate the compliance with drug treatment in patients with metabolic syndrome. 2) To determine association between access to and use of medicines, as…”
    Get full text
    Journal Article
  3. 3

    The Burden of Chronic Urticaria from Brazilian Patients’ Perspective by Balp, Maria-Magdalena, Lopes da Silva, Nilcéia, Vietri, Jeffrey, Tian, Haijun, Ensina, Luis F.

    Published in Dermatology and therapy (01-12-2017)
    “…Introduction Chronic urticaria (CU), a proxy for chronic spontaneous urticaria, has been associated with a negative impact on health-related quality of life…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Humanistic and Economic Impact of Moderate to Severe Plaque Psoriasis in Brazil by Lopes, Nilcéia, Dias, Leticia L. S., Azulay-Abulafia, Luna, Oyafuso, Luiza K. M., Suarez, Maria Victoria, Fabricio, Lincoln, Kobata, Clarice Marie, Cestari, Tania, Gontijo, Bernardo, Sabbag, Cid Y., Antonio, João R., Romiti, Ricardo, Pertel, Patricia C.

    Published in Advances in therapy (01-10-2019)
    “…Introduction Psoriasis is an immune-mediated, chronic, inflammatory disease, which has a substantial humanistic and economic burden. This study aimed to assess…”
    Get full text
    Journal Article
  6. 6

    Cost analysis of multiple sclerosis in Brazil: a cross-sectional multicenter study by da Silva, Nilceia Lopes, Takemoto, Maira L S, Damasceno, Alfredo, Fragoso, Yara D, Finkelsztejn, Alessandro, Becker, Jefferson, Gonçalves, Marcus V M, Tilbery, Charles, de Oliveira, Enedina M L, Callegaro, Dagoberto, Boulos, Fernanda C

    Published in BMC health services research (24-03-2016)
    “…Multiple sclerosis (MS) is a central nervous system disease associated with irreversible progression of disability, which imposes a substantial socioeconomic…”
    Get full text
    Journal Article
  7. 7

    Cost-effectiveness of omalizumab add-on to standard-of-care therapy in patients with uncontrolled severe allergic asthma in a Brazilian healthcare setting by Suzuki, Cibele, Lopes da Silva, Nilceia, Kumar, Praveen, Pathak, Purnima, Ong, Siew Hwa

    Published in Journal of medical economics (03-08-2017)
    “…Omalizumab add-on to standard-of-care therapy has proven to be efficacious in severe asthma patients for whom exacerbations cannot be controlled otherwise…”
    Get more information
    Journal Article
  8. 8

    Differences in utility scores obtained through Brazilian and UK value sets: a cross-sectional study by Takemoto, Maíra Libertad Soligo, Lopes da Silva, Nilceia, Ribeiro-Pereira, Ana Carolina Padula, Schilithz, Arthur Orlando Correa, Suzuki, Cibele

    Published in Health and quality of life outcomes (06-08-2015)
    “…Multiple sclerosis (MS) is a chronic disease associated with several impacts; especially regarding patients' health-related quality of life (HRQL). EuroQol 5…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Cost of severe asthma in Brazil-systematic review by Stirbulov, Roberto, Lopes da Silva, Nilceia, Maia, Sarah Cristina Oliveira Machado, Carvalho-Netto, Eduardo, Angelini, Luciene

    Published in The Journal of asthma (25-11-2016)
    “…Introduction: Severe asthma is characterized by frequent exacerbations, symptoms limiting daily activities and nocturnal symptoms. It requires the continuous…”
    Get full text
    Journal Article